Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic… Read more
Vimian Group AB (publ) (VIMGF) - Total Liabilities
Latest total liabilities as of December 2025: $401.00 Million USD
Based on the latest financial reports, Vimian Group AB (publ) (VIMGF) has total liabilities worth $401.00 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vimian Group AB (publ) - Total Liabilities Trend (2018–2025)
This chart illustrates how Vimian Group AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Vimian Group AB (publ) Competitors by Total Liabilities
The table below lists competitors of Vimian Group AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wisdom Marine Lines Co Ltd
TW:2637
|
Taiwan | NT$1.10 Billion |
|
Lecron Energy Saving Materials
SHE:300343
|
China | CN¥503.63 Million |
|
Basic-Fit N.V
PINK:BSFFF
|
USA | $3.15 Billion |
|
JEPA
F:JEPA
|
Germany | €37.43 Billion |
|
United Fire Group Inc
NASDAQ:UFCS
|
USA | $2.86 Billion |
|
Huhtamaki Oyj
NYSE:HMKIY
|
USA | $2.64 Billion |
|
Anhui Jiangnan Chemical Industry Co Ltd
SHE:002226
|
China | CN¥8.02 Billion |
|
Rent-A-Center Inc
F:RAC
|
Germany | €2.52 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Vimian Group AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vimian Group AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vimian Group AB (publ) (2018–2025)
The table below shows the annual total liabilities of Vimian Group AB (publ) from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $401.00 Million | -0.57% |
| 2024-12-31 | $403.30 Million | -9.77% |
| 2023-12-31 | $446.97 Million | +1.11% |
| 2022-12-31 | $442.06 Million | +56.72% |
| 2021-12-31 | $282.08 Million | +54.95% |
| 2020-12-31 | $182.05 Million | +286.72% |
| 2019-12-31 | $47.08 Million | +244.90% |
| 2018-12-31 | $13.65 Million | -- |